SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001714899-20-000027
Filing Date
2020-02-28
Accepted
2020-02-27 18:14:59
Documents
3
Effectiveness Date
2020-02-28

Document Format Files

Seq Description Document Type Size
1 S-8 forms-82020.htm S-8 154485
2 EX-5.1 exhibit512020.htm EX-5.1 7572
3 EX-23.1 exhibit2312020.htm EX-23.1 2671
  Complete submission text file 0001714899-20-000027.txt   165742
Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-236729 | Film No.: 20664427
SIC: 2836 Biological Products, (No Diagnostic Substances)